Stock Research for JAZZ

JAZZ

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

JAZZ Stock Chart & Research Data

The JAZZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JAZZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


JAZZ Due diligence Resources & Stock Charts

The JAZZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View JAZZ Detailed Price Forecast - CNN Money CNN View JAZZ Detailed Summary - Google Finance
Yahoo View JAZZ Detailed Summary - Yahoo! Finance Zacks View JAZZ Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View JAZZ Trends & Analysis - Trade-Ideas Barrons View JAZZ Major Holders - Barrons
NASDAQ View JAZZ Call Transcripts - NASDAQ Seeking View JAZZ Breaking News & Analysis - Seeking Alpha
Spotlight View JAZZ Annual Report - CompanySpotlight.com OTC Report View JAZZ OTC Short Report - OTCShortReport.com
TradeKing View JAZZ Fundamentals - TradeKing Charts View JAZZ SEC Filings - Bar Chart
WSJ View Historical Prices for JAZZ - The WSJ Morningstar View Performance/Total Return for JAZZ - Morningstar
MarketWatch View the Analyst Estimates for JAZZ - MarketWatch CNBC View the Earnings History for JAZZ - CNBC
StockMarketWatch View the JAZZ Earnings - StockMarketWatch MacroAxis View JAZZ Buy or Sell Recommendations - MacroAxis
Bullish View the JAZZ Bullish Patterns - American Bulls Short Pains View JAZZ Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View JAZZ Stock Mentions - StockTwits PennyStocks View JAZZ Stock Mentions - PennyStockTweets
Twitter View JAZZ Stock Mentions - Twitter Invest Hub View JAZZ Investment Forum News - Investor Hub
Yahoo View JAZZ Stock Mentions - Yahoo! Message Board Seeking Alpha View JAZZ Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for JAZZ - SECform4.com Insider Cow View Insider Transactions for JAZZ - Insider Cow
CNBC View JAZZ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for JAZZ - OTC Markets
Yahoo View Insider Transactions for JAZZ - Yahoo! Finance NASDAQ View Institutional Holdings for JAZZ - NASDAQ


Stock Charts

FinViz View JAZZ Stock Insight & Charts - FinViz.com StockCharts View JAZZ Investment Charts - StockCharts.com
BarChart View JAZZ Stock Overview & Charts - BarChart Trading View View JAZZ User Generated Charts - Trading View




Latest Financial News for JAZZ


Free Daily Technical Summary Reports on Iovance Biotherapeutics and Three Other Biotech Stocks
Posted on Wednesday July 18, 2018

LONDON, UK / ACCESSWIRE / July 18, 2018 / If you want a free Stock Review on IOVA sign up now at www.wallstequities.com/registration. Gains were broad based as six out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Biotechnology stocks: GlycoMimetics Inc. (NASDAQ: GLYC), Iovance Biotherapeutics Inc. (NASDAQ: IOVA), Jaguar Health Inc. (NASDAQ: JAGX), and Jazz Pharmaceuticals PLC (NASDAQ: JAZZ).


See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.
Posted on Tuesday July 17, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.


U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
Posted on Friday July 13, 2018

A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine. The U.S. Court of Appeals for the Federal Circuit affirmed a series of rulings in favor of Amneal that the Jazz patents described obvious ideas. Shares of Jazz fell 2.5 percent to $175 in morning trading, while Amneal was up 1 percent to $18.50.


Morgan Stanley Downgrades Jazz Pharmaceuticals As Stock Approaches Price Target
Posted on Wednesday July 11, 2018

Morgan Stanley analyst wants to move to the sidelines on  Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) as the stock has gained around 34 percent year-to-date and approached his price target of $183. The Analyst ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.